Renaissance Technologies (RenTech)'s MRVI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 4.23 M shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $13.73 M, representing 0.02% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in MRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 1.8 M shares. Largest reduction occurred in Q2 2023, reducing 751,325 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Maravai LifeSciences Holdings (MRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -93,000 | Reduce 2.15% | 4.23 M | $3.25 |
| Q3 2025 | +131,900 | Add 3.15% | 4.32 M | $2.87 |
| Q2 2025 | +75,500 | Add 1.84% | 4.19 M | $2.41 |
| Q1 2025 | +138,500 | Add 3.49% | 4.11 M | $2.21 |
| Q4 2024 | -166,286 | Reduce 4.02% | 3.97 M | $5.45 |
| Q3 2024 | +257,034 | Add 6.62% | 4.14 M | $8.31 |
| Q2 2024 | +668,552 | Add 20.81% | 3.88 M | $7.16 |
| Q1 2024 | +327,200 | Add 11.34% | 3.21 M | $8.67 |
| Q4 2023 | +226,000 | Add 8.50% | 2.89 M | $6.55 |
| Q3 2023 | +218,514 | Add 8.95% | 2.66 M | $10.00 |
| Q2 2023 | -751,325 | Reduce 23.53% | 2.44 M | $0.01 |
| Q1 2023 | -134,448 | Reduce 4.04% | 3.19 M | $0.01 |
| Q4 2022 | +1.8 M | Add 118.49% | 3.33 M | $0.01 |
| Q3 2022 | -352,300 | Reduce 18.79% | 1.52 M | $25.53 |
| Q2 2022 | +961,800 | Add 105.32% | 1.88 M | $28.41 |
| Q1 2022 | +368,400 | Add 67.62% | 913,200 | $35.27 |
| Q4 2021 | -405,281 | Reduce 42.66% | 544,800 | $41.90 |
| Q3 2021 | +305,281 | Add 47.35% | 950,081 | $49.08 |
| Q2 2021 | +644,800 | New Buy | 644,800 | $41.73 |
Renaissance Technologies (RenTech)'s Maravai LifeSciences Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q2 2021, acquiring 644,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Maravai LifeSciences Holdings, Inc. (MRVI) for 19 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q4 2022, adding 3,326,948 shares worth $47,609.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 4,225,089 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $13.73 M.
As of the Q4 2025 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.02% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 4,318,089 shares, as reported at the end of Q3 2025.